Abstract
Purpose
To date, the standard therapy used for acute episodes of uncomplicated sigmoid diverticulitis has been a 7–10-day antibiotic treatment regimen. Thanks to the development of highly potent, broad-spectrum antibiotics such as ertapenem, the question arises as to whether the duration of treatment of acute uncomplicated sigmoid diverticulitis can be reduced by using highly effective antibiotics.
Methods
To compare the efficacy of short-term therapy (4 days) versus standard therapy (7 days) for uncomplicated sigmoid diverticulitis, a prospective randomized multicenter trial was conducted. Patients were randomized to treatment groups after 4 days. Both patient groups were monitored until discharge and were followed up after 4–6 weeks and 52 months. The results were standardized and statistically evaluated.
Results
Between 16 December 2004 and 15 November 2007, 123 patients from 11 hospitals were enrolled in the study. Seventeen patients dropped out. In the remaining 106 cases, no significant differences were discerned between the two groups in terms of the basic data, apart from the mean number of diverticulitis episodes (short term 1.28 ± 0.64 versus standard 1.64 ± 1.07, p = 0.037). The mean hospital stay was 8.8 days, with significant differences seen between short-term and standard therapy (7.8 ± 2.8 versus 9.7 ± 3.2 days; p = 0.002). After 4 days, treatment was classified as having proved successful in 98.0% of cases and after 7 days in 98.2% of cases. An overall success rate of 95.1% (94.0% versus 96.2%, n.s.) was recorded after 1 month.
Conclusion
The results obtained with short-term ertapenem therapy (4 days) showed that this was as effective as standard therapy (7 days) for treatment of uncomplicated sigmoid diverticulitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Schlechter S, Mulvey J, Eisenstat TE (1999) Management of uncomplicated acute diverticulitis. Dis Colon Rectum 42:470–476
Chapman JR, Dozois EJ, Wolff BG, Gullerud RE, Larson DR (2006) Diverticulitis: a progressive disease? Ann Surg 243:876–883
Jacobs DO (2007) Clinical practice. Diverticulitis N Engl J Med 357:2057–2066
Stollman N, Raskin JB (2004) Diverticular disease of the colon. Lancet 363:631–639
Ambrosetti P, Robert JH, Witzig JA, Mirescu D, Mathey P, Borst F, Rohner A (1994) Acute left colonic diverticulitis: a prospective analysis of 226 consecutive cases. Surgery 115:546–550
Roberts P, Abel M, Rosen L, Cirocco W, Fleshman J, Leff E, Levien D, Pritchard T, Wexner S, Hicks T, Kennedy H, Oliver G, Reznick R, Robertson H, Robertson W, Ross T, Rothenberger D, Senatore P, Surell J, Wong WD (1995) Practice parameters for sigmoid diverticulitis-supporting documentation. Dis Colon Rectum 38:126–132
Mäkelä J, Vuolio S, Kiviniemi H, Laitinen S (1998) Natural history of diverticular disease: when to operate? Dis Colon Rectum 41:1523–1528
Rafferty J, Shellito P, Hyman NH, Buie WD, Standards Committee of the American Society of Colon and Rectal Surgeons (2006) Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 49:939–944
Slama TG (2008) Gram-negative antibiotic resistance: there is a price to pay. Critical Care 12(Suppl 4):S4, Epub 2008 May 21
Cunha BA (2004) Overview of antibiotic therapy. In: Cunha BA (ed) Antibiotic essentials, 3rd edn. Physicians, Michigan, pp 4–17
Falagas ME, Peppas G, Makris GC, Karageorgopoulos DE, Matthaiou DK (2008) Meta-analysis: ertapenem for complicated intra-abdominal infections. Aliment Pharmacol Ther 27:919–931
DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abrahamson MA, Teppler H (2005) Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. Antimicrob Agents Chemother 49:3217–3221
Basoli A, Chirletti P, Cirino E, D´Ovidio NG, Doglietto GB, Giglio D, Giulini SM, Malizia A, Taffurelli M, Petrovic J, Ecari M, Italian Study Group (2008) A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs ≥5 days in community-acquired intraabdominal infection. J Gastrointest Surg 12:592–600
Kellum JM, Sugerman HJ, Coppa GF, Way LR, Fine R, Herz B, Speck EL, Jackson D, Duma RJ (1992) Randomized, prospective comparison of cefoxitin and gentamicin-clindamycin in the treatment of acute colonic diverticulitis. Clin Ther 14:376–384
Elsakr R, Johnson DA, Younes Z, Oldfield EC 3rd (1998) Antimicrobial treatment of intra-abdominal infections. Dig Dis 16:47–60
Mueller MH, Glatzle J, Kasparek MS, Becker HD, Jehle EC, Zittel TT, Kreis ME (2005) Long-term outcome of conservative treatment in patients with diverticulitis of the sigmoid colon. Eur J Gastroenterol Hepatol 17:649–654
Ferzoco LB, Raptopoulos V, Silen W (1998) Acute diverticulitis. N Engl J Med 21:1521–1526
Ambrosetti P (2008) Acute diverticulitis of the left colon: value of the initial CT and timing of elective colectomy. J Gastrointest Surg 12:1318–1320
Cunha BA (2002) Ertapenem: a review of its microbiologic, pharmacokinetic and clinical aspects. Drugs Today 38:195–213
Shah PM, Isaacs RD (2003) Ertapenem, the first of a new group of carbapenems. J Antimicrob Chemother 52:538–542
Kaiser AM, Jiang JK, Lake JP, Ault G, Artinyan A, Gonzalez-Ruiz C, Essani R, Beart RW Jr (2005) The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 100:910–917
Liljegren G, Chabok A, Wickbom M, Smedh K, Nilsson K (2007) Acute colonic diverticulitis: a systemic review of diagnostic accuracy. Colorectal Dis 9:480–488
Farthmann EH, Rückauer KD, Häring RU (2000) Evidence-based surgery: diverticulitis-a surgical disease? Langenbecks Arch Surg 385:143–151
Reissfelder C, Buhr HJ, Ritz JP (2006) What is the optimal time of surgical intervention after an acute attack of sigmoid diverticulitis: early or late elective laparoscopic resection. Dis Colon Rectum 49:1842–1848
Salem TA, Molloy RG, O´Dwyer PJ (2007) Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease. Dis Colon Rectum 50:1460–1464
Peppas G, Bliziotis IA, Oikonomaki D, Falagas ME (2007) Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol 22:1360–1368
Acknowledgment
We thank MSD Sharp & Dome (Haar, Germany) for the financial support to conduct this prospective randomized trial.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Participating Hospitals:
J. C. Arnold, Dept. of Medicine II, Diakoniekrankenhaus Rotenburg Wümme GmbH, Rotenburg (Wümme), Germany
M. Birth, Dept. of Surgery, HANSE-Klinikum Stralsund GmbH, Stralsund, Germany
E. Faist, Dept. of Surgery, Klinikum Großhadern, Munich, Germany
F. Köckerling, Dept. of Surgery, Klinikum Region Hannover Siloah, Hannover, Germany
H. Lippert, Dept. of Surgery, Universitätsklinikum Magdeburg, Magdeburg, Germany
K. Ludwig, Dept. of Surgery, Südstadt Klinikum, Rostock, Germany
H. J. Meyer, Dept. of Surgery, Städtisches Klinikum Solingen, Solingen, Germany
O. Möschler, Dept. of Medicine, Marienhospital Osnabrück, Osnabrück, Germany
F. Pilz, Dept. of Surgery, BG-Kliniken Bergmannstrost, Halle, Germany
K. Ridwelski, Dept. of Surgery, Städtisches Klinikum Magdeburg, Magdeburg, Germany
L. D. Schreiber, Dept. of Surgery, Hufeland-Krankenhaus, Bad Langensalza, Germany
An erratum to this article can be found at http://dx.doi.org/10.1007/s00384-010-0933-6
Rights and permissions
About this article
Cite this article
Schug-Pass, C., Geers, P., Hügel, O. et al. Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis. Int J Colorectal Dis 25, 751–759 (2010). https://doi.org/10.1007/s00384-010-0899-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-010-0899-4